SLC39A13 Gene Spondylocheirodysplasia Ehlers-Danlos syndrome-like Genetic Test
Are you or a loved one experiencing symptoms of Spondylocheirodysplasia Ehlers-Danlos syndrome-like (SCD-EDS)? DNA Labs UAE offers a comprehensive genetic test to help diagnose this rare genetic disorder.
Test Details
The SLC39A13 gene is associated with SCD-EDS, a condition characterized by skeletal abnormalities, joint hypermobility, and skin findings similar to Ehlers-Danlos syndrome. Our Next-Generation Sequencing (NGS) genetic test utilizes advanced sequencing technology to analyze multiple genes simultaneously.
By identifying mutations or variants in the SLC39A13 gene, our test can provide a definitive diagnosis for individuals suspected of having SCD-EDS. This information is crucial for guiding medical management and understanding the inheritance pattern of the condition.
Test Components and Price
Our SLC39A13 Gene Spondylocheirodysplasia Ehlers-Danlos syndrome-like Genetic Test is priced at 4400.0 AED.
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Reports are typically delivered within 3 to 4 weeks.
Test Type
This test falls under the categories of Osteology, Dermatology, and Immunology Disorders.
Doctor and Test Department
Our genetic test is performed by our experienced dermatologists in our Genetics department.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient who is going for the SLC39A13 Gene Spondylocheirodysplasia Ehlers-Danlos syndrome-like NGS Genetic DNA Test. A genetic counseling session will also be conducted to draw a pedigree chart of family members affected by SCD-EDS.
Genetic Counseling
Genetic testing for SCD-EDS should be ordered and interpreted by a healthcare professional with expertise in genetics. We strongly recommend genetic counseling before and after testing to discuss the implications of the results and provide support for individuals and families.
Don’t wait any longer to get answers. Contact DNA Labs UAE today to schedule your SLC39A13 Gene Spondylocheirodysplasia Ehlers-Danlos syndrome-like Genetic Test and take the first step towards a definitive diagnosis.
Test Name | SLC39A13 Gene Spondylocheirodysplasia Ehlers-Danlos syndrome-like Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SLC39A13 Gene Spondylocheirodysplasia, Ehlers-Danlos syndrome-like NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC39A13 Gene Spondylocheirodysplasia, Ehlers-Danlos syndrome-like NGS Genetic DNA Test gene SLC39A13 |
Test Details |
The SLC39A13 gene is associated with a rare genetic disorder called Spondylocheirodysplasia Ehlers-Danlos syndrome-like (SCD-EDS). This condition is characterized by a combination of skeletal abnormalities, joint hypermobility, and skin findings similar to Ehlers-Danlos syndrome. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of SCD-EDS, NGS genetic testing can be used to identify mutations or variants in the SLC39A13 gene that are associated with this condition. The purpose of this genetic test is to provide a definitive diagnosis for individuals suspected of having SCD-EDS. It can help confirm the presence of specific mutations in the SLC39A13 gene, which can guide medical management and provide information about the inheritance pattern of the condition. It’s important to note that genetic testing for SCD-EDS should be ordered and interpreted by a healthcare professional with expertise in genetics. Genetic counseling is also recommended before and after testing to discuss the implications of the results and provide support for individuals and families. |